Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, October 24, 2026

Back to today

Tower Semiconductor Deep Dive

Tower Semiconductor’s low-loss photonics chips halve lasers in 1.6T optical modules, supporting a $680 million annualized photonics run rate and customer wafer prepayments through 2027.

TSEM $19B
CV's Substack 9 clicks

From X

@StableBread 2 clicks

Fajasy on X

Newbury Street II $NTWO, the SPAC taking robot-safety maker FORT Robotics public, closed at $10.81 on October 9, below the cash in its trust. The final proxy for its October 28, 2026 extension vote, filed the same day, shows $186.9M in the trust as of October 7, or $10.833/share. The vote would push Newbury's deadline for closing the deal from November 4 to February 4, 2027, and holders who want to cash out at $10.833 have until 5pm EST on October 26 to submit their shares. The proxy also says the S-4 (the merger filing) is still "to be filed," 52 days after FORT CEO Samuel Reeves told employees to expect it "in the coming weeks." So at $10.81, the market values the FORT deal at zero, and holders who skip this redemption can still cash out at the merger vote, once they've seen the S-4.
@StableBread 1 click

Fajasy on X

Neither of the two commercial prospects BWX Technologies $BWXT has named for its BANR microreactor is a data center. 1) Prodigy Clean Energy, a Montreal-based developer of factory-built nuclear plants: Two BANRs for a transportable pilot plant in Belledune, New Brunswick, built mainly at $BWXT’s Ontario plants and running in the early 2030s. New Brunswick’s government signed a letter of intent (LOI) to buy the power. $BWXT and Prodigy are still negotiating a definitive agreement, and the release provides no dollar value. 2) Tata Chemicals Soda Ash: A Wyoming soda ash producer that signed an LOI to explore deploying up to eight BANRs. $BWXT also markets BANR to data centers. However, I found no data center contract, customer, LOI, or revenue in any $BWXT press release from January 2025 through October 2026, in the FY2025 10-K, or in the 2026 10-Qs. $BWXT’s own mentions stop at a product page saying BANR can provide “clean electricity for municipalities, data centers and campuses,” and slides 11 and 25 from its Investor Day on September 29, 2026, which list “AI/data center demand” as a driver of nuclear demand in general. I didn’t hear the phrase “data center” mentioned once during Investor Day, and slide 49 lists data centers in the third phase of $BWXT’s microreactor plan. CEO Rex Geveden said at Investor Day that “the incremental demand from AI right now is 60 GW” and “winning at AI means winning at power, and winning at power probably means having a nuclear solution.” If he’s right, $BWXT benefits by supplying components, fuel, and services to more reactors, not by selling microreactors to data centers. Advanced Reactor Design and Engineering, the product line that includes Project Pele (its prototype microreactor for the Pentagon) and $BWXT’s other microreactor programs, brought in $203.8M in 2024 and $147.1M in 2025, then $52.6M in H1 2026, down from $69.8M a year earlier. At 3.0% of $BWXT’s $1,761.8M of H1 2026 revenue, microreactors are still a small, early business.

Investor Letters

All letters

Margin Call

Petrobras’s Morpho-1 well revived hopes that Brazil’s Equatorial Margin can become a major new oil frontier after hydrocarbons were…

PBR $83B
Doomberg 9 clicks

Our Views on CoreWeave

CoreWeave's financial statements point to a business model familiar to the authors after a closer review of the AI infrastructure company.

CRWV $30B
WHAT ARE WE DOING? “Contrarians At The Gate” 12 clicks

Capital Wars

CoreWeave’s $35 billion to $39 billion 2026 spending plan relies on debt as unsecured yields reach 15%, making its GPU cloud expansion a…

CRWV $30B
Net Interest 12 clicks

Putting bear cases to rest

Medpace authorized $1 billion of buybacks through 2028 after Q3 revenue rose 8.5% to $716 million; service revenue grew roughly 12% as…

MEDP $18B
Best Anchor Stocks 14 clicks
PYPD · long

Polypid LTD

PolyPid, an $80 million Israeli biotech, fell nearly 30% despite solving a clinical problem.

PYPD $106M
Value Investors Club

MYR Group q3’26 Earnings Preview

MYR Group’s Q3 2026 preview cites data-center and power transmission demand, with long-term service agreements supporting margin growth and…

MYRG $4B
Monte Independent Investment Research 5 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 62 of 255

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.